The Oncology Institute, Inc. TOI Other long-term liabilities
Other long-term liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other long-term liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other long-term liabilities?
- The Oncology Institute, Inc. (TOI) reported other long-term liabilities of $0 in Q1 2026.
- How has The Oncology Institute, Inc.'s other long-term liabilities changed year-over-year?
- The Oncology Institute, Inc.'s other long-term liabilities decreased by 100.0% year-over-year, from $1K to $0.
- What is the long-term trend for The Oncology Institute, Inc.'s other long-term liabilities?
- Over 3 years (2021 to 2024), The Oncology Institute, Inc.'s other long-term liabilities has grown at a -36.8% compound annual growth rate (CAGR), from $809K to -$204K.